Dow Up 0.89% Nasdaq Up 1.69%

More On CANF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Can-Fite BioPharma Ltd. (CANF)

-NYSE MKT
3.09 Down 0.03(0.96%) 1:18PM EDT - Nasdaq Real Time Price
Prev Close:3.12
Open:3.07
Bid:3.09 x 100
Ask:3.15 x 100
1y Target Est:28.00
Beta:1.163
Next Earnings Date:N/A
Day's Range:3.03 - 3.09
52wk Range:3.00 - 9.46
Volume:1,500
Avg Vol (3m):14,789
Market Cap:27.33M
P/E (ttm):N/A
EPS (ttm):-0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CANF

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback